Cellcor, Cytogen deal

CYTO signed a definitive agreement to acquire CLTX, a Newton, Mass., developer of autolymphocyte therapies (ALT) for cancer and infectious diseases.

CYTO (Princeton, N.J.) will issue

Read the full 260 word article

How to gain access

Continue reading with a
two-week free trial.